ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 694,82
0,42%
Dow Jones
39 112,16
-0,76%
DAX
18 293,26
0,72%
Brent Oil
84,645
0,55%
Bitcoin
61 729,17
-0,13%
Registration Strip Icon for monitor Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Biofrontera Inc (BFRI)

  7. Biofrontera Inc (BFRI) Actualités

BFRI

Biofrontera (BFRI)

Biofrontera Inc
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:BFRI
DateHeureSourceTitreSymboleSociété
24/06/202414h30GlobeNewswire Inc.Biofrontera Announces the Launch of a New, FDA-Approved Red Light Source, the RhodoLED® XL LampNASDAQ:BFRIBiofrontera Inc
08/03/202423h14Edgar (US Regulatory)Form PRE 14A - Other preliminary proxy statementsNASDAQ:BFRIBiofrontera Inc
05/03/202423h20Edgar (US Regulatory)Form D - Notice of Exempt Offering of SecuritiesNASDAQ:BFRIBiofrontera Inc
23/02/202415h26Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:BFRIBiofrontera Inc
20/02/202413h55Edgar (US Regulatory)Form RW - Registration Withdrawal RequestNASDAQ:BFRIBiofrontera Inc
09/01/202423h01Edgar (US Regulatory)Form 8-K/A - Current report: [Amend]NASDAQ:BFRIBiofrontera Inc
17/11/202312h02Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:BFRIBiofrontera Inc
09/11/202323h23Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:BFRIBiofrontera Inc
01/11/202322h09Edgar (US Regulatory)Form 424B4 - Prospectus [Rule 424(b)(4)]NASDAQ:BFRIBiofrontera Inc
31/10/202305h15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:BFRIBiofrontera Inc
05/10/202303h48Edgar (US Regulatory)Form S-1 - General form for registration of securities under the Securities Act of 1933NASDAQ:BFRIBiofrontera Inc
22/08/202322h30Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:BFRIBiofrontera Inc
20/06/202322h31Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:BFRIBiofrontera Inc
28/04/202315h12Edgar (US Regulatory)Amended Securities Registration (section 12(b)) (8-a12b/a)NASDAQ:BFRIBiofrontera Inc
11/04/202322h44Edgar (US Regulatory)Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)NASDAQ:BFRIBiofrontera Inc
16/12/202214h30GlobeNewswire Inc.Biofrontera Inc. Announces Voting Results from 2022 Annual Meeting of StockholdersNASDAQ:BFRIBiofrontera Inc
08/12/202222h06Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:BFRIBiofrontera Inc
30/11/202220h08GlobeNewswire Inc.Biofrontera Inc. to Participate in Benchmark’s 11th Annual Discovery One-on-One Investor ConferenceNASDAQ:BFRIBiofrontera Inc
28/11/202217h05GlobeNewswire Inc.BIOFRONTERA INC. TO PARTICIPATE IN RENMARK’S VIRTUAL NON-DEAL ROADSHOW SERIES ON WEDNESDAY, NOVEMBER 30, MONDAY, DECEMBER 5, FRIDAY, DECEMBER 9, AND MONDAY, DECEMBER 19 2022NASDAQ:BFRIBiofrontera Inc
21/11/202214h48GlobeNewswire Inc.Biofrontera to Launch Phase 3 Clinical Study Evaluating Ameluz®-PDT for the Treatment of Actinic Keratosis on the Extremities, Neck and TrunkNASDAQ:BFRIBiofrontera Inc
15/11/202223h29Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)NASDAQ:BFRIBiofrontera Inc
14/11/202214h59Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:BFRIBiofrontera Inc
14/11/202214h45GlobeNewswire Inc.Biofrontera Inc. Reports Third Quarter 2022 Financial Results and Provides a Business UpdateNASDAQ:BFRIBiofrontera Inc
14/11/202212h05Edgar (US Regulatory)Revised Proxy Soliciting Materials (definitive) (defr14a)NASDAQ:BFRIBiofrontera Inc
10/11/202217h52GlobeNewswire Inc.Biofrontera Inc. to Report Third Quarter Financial Results on November 14, 2022NASDAQ:BFRIBiofrontera Inc
08/11/202222h45GlobeNewswire Inc.Biofrontera Inc. Fully Exercises Recently Acquired Options to Purchase Shares of Biofrontera AGNASDAQ:BFRIBiofrontera Inc
08/11/202212h04Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:BFRIBiofrontera Inc
04/11/202221h06Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:BFRIBiofrontera Inc
03/11/202211h06Edgar (US Regulatory)Securities Registration Statement (s-1)NASDAQ:BFRIBiofrontera Inc
31/10/202213h55GlobeNewswire Inc.Biofrontera Inc. Enters into Agreements to Purchase Options of Biofrontera AGNASDAQ:BFRIBiofrontera Inc
 Showing the most relevant articles for your search:NASDAQ:BFRI

Dernières Valeurs Consultées

LSE
77BH
Hsbc Bk. 39
USOTC
JMPHF
Leveljump Healthcare (PK)
TSX
TXT.UN
Top Ten Split
TSXV
SEP.P
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés